Incretin-Based Drugs Market Size, Share, Demand, Trends, Growth and 2027 Forecasts : Analysis by AstraZeneca Plc, Boehringer Ingelheim GmbH, Eli Lilly and Company
The major drivers of global incretin-based drugs market are the sedentary lifestyle, rising old age population, increasing rate of cardiovascular diseases, obesity, increasing incidence of diabetes, and raising awareness of diabetes.
View full press release